Group 1 - The Hong Kong Innovative Drug ETF Penghua (159286) experienced a decline of 1.72% on November 18, with a trading volume of 83.8677 million yuan [1] - The fund's shares increased by 3 million, bringing the total shares to 673 million, with a total increase of 63 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 613 million yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF Penghua is the National Index of Hong Kong Innovative Drugs, adjusted for exchange rates [1] - The fund is managed by Penghua Fund Management Co., Ltd., with fund managers Lin Song and Zhang Yuxiang [1] - Since its establishment on August 20, 2025, the fund has returned -8.91%, with a return of -0.55% over the past month [1]
11月18日港股创新药ETF鹏华（159286）份额增加300.00万份，最新份额6.73亿份，最新规模6.13亿元
Xin Lang Cai Jing·2025-11-19 04:52